V
PCVX
Vaxcyte, Inc.
47.46
+0.17+0.36%After Hours: 46.90 -0.56 -1.18%19:03 06/12 EDT
OPEN/PREV CLOSE47.30/47.29
TODAY RANGE46.71-48.44
VOL1.03M
MARKET CAP6.85B
52 WEEK RANGE29.08-65.00
AVG VOL (3M)1.43M
% TURNOVER0.71%
TURNOVER--
P/E (TTM)-6.8859
% RANGE3.66%
EPS(TTM)-6.8923
P/E(FORWARD)-5.4709
P/B2.286
BVPS20.76
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.82B
SHARES OUTSTANDING144.40M
NEXT EARNINGS08/04-08/10
FREE FLOAT143.61M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·15h ago
Did Vaxcyte’s (PCVX) First-in-Human Strep Vaccine Trial Just Reframe Its Pipeline Ambitions?
Simply Wall St·5d ago
Vaxcyte (PCVX) Valuation Check As VAX A1 Begins Phase 1 Group A Strep Trial
Simply Wall St·06/04 22:25
Does Vaxcyte’s First-in-Human Group A Strep Trial Reshape The Bull Case For Vaxcyte (PCVX)?
TipRanks·06/03 00:16
Vaxcyte (PCVX) Has a New Rating from Mizuho Securities
TipRanks·06/02 20:28
Vaxcyte doses first participant in VAX-A1 study
Reuters·06/02 20:05
VAXCYTE - EXPECTS TOPLINE DATA FROM VAX-A1 PHASE 1 STUDY IN H2 2027
Simply Wall St·05/29 14:06
Assessing Vaxcyte (PCVX) Valuation After Mixed Short And Long Term Share Price Moves
Dow Jones·05/26 11:30
S&P 500 Futures Climb In Premarket Trading; MDA Space, ViaSat Lead
Benzinga·05/26 10:08
Top 3 Health Care Stocks You'll Regret Missing In May
Simply Wall St·05/20 18:31
Why Vaxcyte (PCVX) Is Down 9.7% After Steeper Q1 Losses And Accelerated R&D Spending
Same Industry
Name/Symbol
Change%
Price